{"title":"Biocompatibility and antibacterial activity of strontium and silver ion-releasing titanium with high silver treatment concentration.","authors":"Kazuki Orita, Shunsuke Fujibayashi, Yaichiro Okuzu, Seiji Yamaguchi, Koji Goto, Bungo Otsuki, Toshiyuki Kawai, Takayoshi Shimizu, Makoto Hayashi, Norimasa Ikeda, Yusuke Takaoka, Shintaro Honda, Tatsuhito Ikezaki, Shuichi Matsuda","doi":"10.1177/08853282251329276","DOIUrl":null,"url":null,"abstract":"<p><p>To overcome problems associated with surgical site infection and implant loosening, we developed a titanium (Ti)-based material employing a modified alkaline heat treatment that releases strontium (Sr) and silver (Ag) ions (CaSrAg-Ti). In this study, to determine the optimal Ag treatment concentration, we prepared four different materials-commercially pure Ti (cp-Ti) as a negative control, CaSr1mMAg-Ti, CaSr10mMAg-Ti, and CaSr50mMAg-Ti. Ion release test was performed by immersing the prepared disks in fetal bovine serum. With increased loading of Ag ions, the amount of released ions increased. Colony-forming unit count assay was performed using methicillin-susceptible <i>Staphylococcus aureus</i> and <i>Escherichia coli</i>. High antibacterial activity was observed in CaSr10mMAg-Ti and CaSr50mMAg-Ti groups. <i>In vivo</i> experiments were performed using the rat subcutaneous pocket infection model and evaluated by counting the attached bacteria, wound appearance, and histological evaluation. High antibacterial activity value (AAV >2) and anti-inflammatory effects were observed in the CaSr50mMAg-Ti group. However, CaSr10mMAg-Ti did not exhibit consistent antibacterial activity. For <i>in vivo</i> biocompatibility and bone-bonding ability evaluation, rods were implanted into the rat femur. No cytotoxicity was observed at 1 week, and good bone-bonding ability at 4 and 8 weeks was not significantly different from that of CaSr1mMAg-Ti. To evaluate <i>in vivo</i> bioactivity and cytotoxicity, MC3T3-E1 cells were cultured on disks. CaSr10mMAg-Ti and CaSr50mMAg-Ti significantly inhibited the proliferation and differentiation of MC3T3E1 cells, as well as the production of extracellular matrix <i>in vivo</i>, despite showing good biocompatibility <i>in vivo</i>. In conclusion, CaSr50mMAg-Ti, with increased Ag ion loading, exhibited high antibacterial activity <i>in vivo</i> while maintaining the bone-bonding ability and is a promising therapeutic biomaterial. Further research is needed to determine the optimal combination of therapeutic concentrations of Sr and Ag.</p>","PeriodicalId":15138,"journal":{"name":"Journal of Biomaterials Applications","volume":" ","pages":"20-35"},"PeriodicalIF":2.3000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biomaterials Applications","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1177/08853282251329276","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/20 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
To overcome problems associated with surgical site infection and implant loosening, we developed a titanium (Ti)-based material employing a modified alkaline heat treatment that releases strontium (Sr) and silver (Ag) ions (CaSrAg-Ti). In this study, to determine the optimal Ag treatment concentration, we prepared four different materials-commercially pure Ti (cp-Ti) as a negative control, CaSr1mMAg-Ti, CaSr10mMAg-Ti, and CaSr50mMAg-Ti. Ion release test was performed by immersing the prepared disks in fetal bovine serum. With increased loading of Ag ions, the amount of released ions increased. Colony-forming unit count assay was performed using methicillin-susceptible Staphylococcus aureus and Escherichia coli. High antibacterial activity was observed in CaSr10mMAg-Ti and CaSr50mMAg-Ti groups. In vivo experiments were performed using the rat subcutaneous pocket infection model and evaluated by counting the attached bacteria, wound appearance, and histological evaluation. High antibacterial activity value (AAV >2) and anti-inflammatory effects were observed in the CaSr50mMAg-Ti group. However, CaSr10mMAg-Ti did not exhibit consistent antibacterial activity. For in vivo biocompatibility and bone-bonding ability evaluation, rods were implanted into the rat femur. No cytotoxicity was observed at 1 week, and good bone-bonding ability at 4 and 8 weeks was not significantly different from that of CaSr1mMAg-Ti. To evaluate in vivo bioactivity and cytotoxicity, MC3T3-E1 cells were cultured on disks. CaSr10mMAg-Ti and CaSr50mMAg-Ti significantly inhibited the proliferation and differentiation of MC3T3E1 cells, as well as the production of extracellular matrix in vivo, despite showing good biocompatibility in vivo. In conclusion, CaSr50mMAg-Ti, with increased Ag ion loading, exhibited high antibacterial activity in vivo while maintaining the bone-bonding ability and is a promising therapeutic biomaterial. Further research is needed to determine the optimal combination of therapeutic concentrations of Sr and Ag.
期刊介绍:
The Journal of Biomaterials Applications is a fully peer reviewed international journal that publishes original research and review articles that emphasize the development, manufacture and clinical applications of biomaterials.
Peer-reviewed articles by biomedical specialists from around the world cover:
New developments in biomaterials, R&D, properties and performance, evaluation and applications
Applications in biomedical materials and devices - from sutures and wound dressings to biosensors and cardiovascular devices
Current findings in biological compatibility/incompatibility of biomaterials
The Journal of Biomaterials Applications publishes original articles that emphasize the development, manufacture and clinical applications of biomaterials. Biomaterials continue to be one of the most rapidly growing areas of research in plastics today and certainly one of the biggest technical challenges, since biomaterial performance is dependent on polymer compatibility with the aggressive biological environment. The Journal cuts across disciplines and focuses on medical research and topics that present the broadest view of practical applications of biomaterials in actual clinical use.
The Journal of Biomaterial Applications is devoted to new and emerging biomaterials technologies, particularly focusing on the many applications which are under development at industrial biomedical and polymer research facilities, as well as the ongoing activities in academic, medical and applied clinical uses of devices.